1- arabinofuranosylcytosine- 5'- stearylphosphate

02/06/2015 - "Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate."
05/01/1997 - "Cytarabine ocfosfate (Nippon Kayaku) has already put on market as the first drug to be active against ANLL and MDS by giving orally."
03/01/1994 - "[Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate]."
05/01/1995 - "[Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia]."
10/01/1998 - "Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics."

07/01/2000 - "Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study."
04/01/2002 - "Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase."
07/01/2000 - "The efficacy of continuous oral cytarabine ocfosfate (YNK01) (300 mg/day) in combination with interferon alpha (IFNalpha, 5x10(6) IU/day) was evaluated in patients with advanced chronic myelogenous leukemia, who previously failed to respond to IFNalpha-based therapies. "
02/01/2002 - "We report a case of chronic myelogenous leukemia (CML) in which the bone marrow achieved cytogenetic complete remission (CCR) achieved by treatment with interferon-alpha and oral cytarabine ocfosfate after extramedullary blast crisis. "
02/01/2002 - "Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis."

01/01/2003 - "A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog."
09/01/1996 - "Five cases of myelodysplastic syndrome were treated with cytarabine ocfosfate. "
09/01/1996 - "[Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate]."
06/01/1994 - "[Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate]."
04/01/1997 - "Cytarabine ocfosfate (SPAC) was administered orally to 19 patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). "

01/01/1995 - "Cytarabine ocfosfate might be a useful drug for the treatment of high risk MDS such as RAEB and RAEB-t."
01/01/1995 - "[Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate]."
01/01/1995 - "[Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T]."
02/01/1999 - "Cytarabine ocfosfate, a derivative of cytosine arabinoside, is a useful agent against acute leukemia and MDS, especially RAEB, RAEB in T, CMMoL. "
01/01/1991 - "1-beta-D-Arabinofuranosylcytosine-5'-stearylphosphate (fosteabine) was administered orally to patients with myelodysplastic syndromes (MDS); refractory anemia with excess of blasts (RAEB), RAEB in transformation, acute leukemia derived from RAEB and chronic myelomonocytic leukemia, in an early phase II study in a multi-institutional study. "

06/01/1994 - "[Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate]."
02/01/1999 - "Cytarabine ocfosfate, a derivative of cytosine arabinoside, is a useful agent against acute leukemia and MDS, especially RAEB, RAEB in T, CMMoL. "
01/01/1991 - "1-beta-D-Arabinofuranosylcytosine-5'-stearylphosphate (fosteabine) was administered orally to patients with myelodysplastic syndromes (MDS); refractory anemia with excess of blasts (RAEB), RAEB in transformation, acute leukemia derived from RAEB and chronic myelomonocytic leukemia, in an early phase II study in a multi-institutional study. "
10/01/1990 - "[A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)]."